Melasma treatment in Korea pairs staged low-fluence pico laser toning — from ₩89,000 (≈ $64) per session at Kind Global Clinic Myeongdong — with strict sun and heat trigger control, because melasma is a relapsing, hormonally driven pigment condition that responds to conservative repetition, not aggressive single passes.
Melasma is not an ordinary dark spot. It is a chronic pigment condition — symmetric brown-to-gray patches across the cheeks, forehead, or upper lip — driven by hormones, ultraviolet exposure, visible light, and heat, with overactive melanocytes that reactivate every time they are provoked. That last property is what makes melasma the condition where laser choice and dosing matter most: a high-energy pass that would erase a sun spot can inflame melasma skin and rebound it darker within weeks. The Korean clinical answer, refined across low-fluence toning cohorts published since 2009, is deliberate under-treatment repeated on schedule — picosecond pulses at reduced fluence, fragmenting pigment mechanically with minimal heat, session after session at 2-to-4-week intervals.
At Kind Global Clinic Myeongdong, that protocol starts with grading rather than a device menu. Dr. Lee Wonjin or Dr. Lee Kangin confirms the patches are melasma and not discrete removable spots, maps depth and activity, screens hormonal and photosensitivity history, and then sets a staged pico toning course on the FDA-cleared PicoSure platform — with fluence recalibrated at every visit against the previous session's response. The broader device landscape is covered on the melasma laser and pigmentation laser pages; this page is about the condition itself and why melasma in Korea is managed conservatively. Every session is physician-performed, and the same published KRW price applies to international and Korean patients.